DEGENERATION OF NIGROSTRIATAL DOPAMINERGIC-NEURONS INCREASES IRON WITHIN THE SUBSTANTIA-NIGRA - A HISTOCHEMICAL AND NEUROCHEMICAL STUDY

被引:133
作者
OESTREICHER, E
SENGSTOCK, GJ
RIEDERER, P
OLANOW, CW
DUNN, AJ
ARENDASH, GW
机构
[1] UNIV S FLORIDA, DEPT BIOL, TAMPA, FL 33620 USA
[2] UNIV S FLORIDA, INST AGING, TAMPA, FL 33620 USA
[3] UNIV S FLORIDA, INST BIOMOLEC SCI, TAMPA, FL 33620 USA
[4] UNIV WURZBURG, DEPT PSYCHIAT, W-8700 WURZBURG, GERMANY
[5] UNIV S FLORIDA, COLL MED, DEPT NUEROL, TAMPA, FL 33612 USA
[6] UNIV S FLORIDA, COLL MED, DEPT PHARMACOL, TAMPA, FL 33612 USA
[7] UNIV S FLORIDA, COLL MED, DEPT PSYCHIAT, TAMPA, FL 33612 USA
[8] LOUISIANA STATE UNIV, MED CTR, DEPT PHARMACOL & THERAPEUT, SHREVEPORT, LA 71130 USA
关键词
IRON; SUBSTANTIA NIGRA; NIGROSTRIATAL DEGENERATION; DOPAMINE;
D O I
10.1016/0006-8993(94)90833-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's-diseased (PD) brains have increased levels of iron in the zona compacta of the substantia nigra (SNc). To determine whether these elevated nigral iron levels may be caused secondarily by degeneration of nigrostriatal dopaminergic (NS-DA) neurons, the NS-DA pathway was unilaterally lesioned in rats through 6-hydroxydopamine (6-OHDA) infusion and nigral iron levels evaluated three weeks later. A significant increase was observed in both iron concentration (+35%) and iron content (+33) within the substantia nigra (SN) ipsilateral to comprehensive 6-OHDA lesions. Moreover, ferric iron staining was dramatically increased within the SNc following 6-OHDA lesions, primarily due to the appearance of iron-positive SNc neurons and infiltrating reactive glial cells. Iron staining in the SN zona reticularis was modestly increased after 6-OHDA lesions, but staining in the neostriatum and globus pallidus was unaffected. These results indicate that loss of NS-DA neurons is associated with increased iron levels in the SN. This suggests that increased nigral iron levels in PD may be secondary to some neurodegenerative process. Nonetheless, even a secondary increase in nigral iron levels may be of pathogenic importance in PD because of iron's ability to catalyze neurotoxic free radical formation and perpetuate neurodegeneration.
引用
收藏
页码:8 / 18
页数:11
相关论文
共 45 条
  • [1] ANTONINI A, 1993, J CEREB BLOOD FLO S1, V13, pS364
  • [2] Arendash G. W., 1994, P175
  • [3] THE IRON CHELATOR DESFERRIOXAMINE (DESFERAL) RETARDS 6-HYDROXYDOPAMINE-INDUCED DEGENERATION OF NIGROSTRIATAL DOPAMINE NEURONS
    BENSHACHAR, D
    ESHEL, G
    FINBERG, JPM
    YOUDIM, MBH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 56 (04) : 1441 - 1444
  • [4] PREVENTION OF NEUROLEPTIC-INDUCED DOPAMINE-D2 RECEPTOR SUPERSENSITIVITY BY CHRONIC IRON SALT TREATMENT
    BENSHACHAR, D
    PINHASSI, B
    YOUDIM, MBH
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 202 (02) : 177 - 183
  • [5] IRON MELANIN INTERACTION AND LIPID-PEROXIDATION - IMPLICATIONS FOR PARKINSONS-DISEASE
    BENSHACHAR, D
    RIEDERER, P
    YOUDIM, MBH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 57 (05) : 1609 - 1614
  • [6] INTRANIGRAL IRON INJECTION INDUCES BEHAVIORAL AND BIOCHEMICAL PARKINSONISM IN RATS
    BENSHACHAR, D
    YOUDIM, MBH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 57 (06) : 2133 - 2135
  • [7] INCREASED NIGRAL IRON CONTENT AND ALTERATIONS IN OTHER METAL-IONS OCCURRING IN BRAIN IN PARKINSONS-DISEASE
    DEXTER, DT
    WELLS, FR
    LEES, AJ
    AGID, F
    AGID, Y
    JENNER, P
    MARSDEN, CD
    [J]. JOURNAL OF NEUROCHEMISTRY, 1989, 52 (06) : 1830 - 1836
  • [8] ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE-METALS IN PARKINSONS-DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA
    DEXTER, DT
    CARAYON, A
    JAVOYAGID, F
    AGID, Y
    WELLS, FR
    DANIEL, SE
    LEES, AJ
    JENNER, P
    MARSDEN, CD
    [J]. BRAIN, 1991, 114 : 1953 - 1975
  • [9] BASAL LIPID-PEROXIDATION IN SUBSTANTIA NIGRA IS INCREASED IN PARKINSONS-DISEASE
    DEXTER, DT
    CARTER, CJ
    WELLS, FR
    JAVOYAGID, F
    AGID, Y
    LEES, A
    JENNER, P
    MARSDEN, CD
    [J]. JOURNAL OF NEUROCHEMISTRY, 1989, 52 (02) : 381 - 389
  • [10] DEXTER DT, 1993, ADV NEUROL, V60, P273